BRAF and cancer: A significant difference in dependency based on copy number status was also observed in the non-mutated cell lines for KRAS, but not for BRAF (Supplementary Fig. S12), suggesting that for KRAS also increasing the non-mutated copy number is beneficial for the cancer cells.